Tema Oncology ETF
CANC
6 hedge funds and large institutions have $4.9M invested in Tema Oncology ETF in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
20% more funds holding
Funds holding: 5 → 6 (+1)
27.64% less ownership
Funds ownership: 33.9% → 6.26% (-28%)
80% less capital invested
Capital invested by funds: $24.1M → $4.9M (-$19.2M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
+$583K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$16.1K |
| 3 |
TCM
TD Capital Management
Memphis,
Tennessee
|
+$9.99K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$21.5M |
| 2 |
Jane Street
New York
|
-$349K |
| 3 |
Raymond James Financial
St Petersburg,
Florida
|
-$21.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
| $4.23M | -$21.5M | -810,003 | -85% |
|
|
FTUS
2
Flow Traders U.S.
New York
| $630K | +$583K | +21,939 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $17.4K | +$16.1K | +605 | New |
|
|
TCM
4
TD Capital Management
Memphis,
Tennessee
| $10.8K | +$9.99K | +376 | New |
|
5
Osaic Holdings
Scottsdale,
Arizona
| $10.6K | – | – | – |
|
|
PS
6
Principal Securities
Des Moines,
Iowa
| $1.44K | – | – | – |
|
|
7
Jane Street
New York
| – | -$349K | -14,104 | Closed |
|
|
8
Raymond James Financial
St Petersburg,
Florida
| – | -$21.6K | -875 | Closed |
|
CANC Hedge Fund Activity: Q3 2025 in Review
6 of the 7,630 institutional investors tracked by Wall St. Rank reported a position in Tema Oncology ETF (CANC) for Q3 2025, worth a combined $4.9M — down 80% from $24.1M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CANC positions and 2 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Flow Traders U.S., opening a new position worth an estimated $583K. The largest seller was Thrivent Financial for Lutherans, cutting an estimated $21.5M.
- 6 institutional investors held Tema Oncology ETF (CANC) as of Q3 2025, up from 5 in Q2 2025.
- Funds reported $4.9M of Tema Oncology ETF stock for Q3 2025, down 80% quarter-over-quarter.
- 3 funds opened new Tema Oncology ETF positions in Q3 2025 and 2 closed out, a net change of +1 holder.
- The largest Tema Oncology ETF buyer in Q3 2025 was Flow Traders U.S., an estimated $583K added.
- The largest Tema Oncology ETF seller in Q3 2025 was Thrivent Financial for Lutherans, an estimated $21.5M sold.
Based on aggregated 13F filings for Q3 2025.